CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Prolung Inc  (FRES)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
 
 

FRES's Revenue Year on Year Growth by Quarter and Year

Prolung Inc's Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
FRES Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 0.01 - -
III Quarter September - - 0.01 0.12
II Quarter June - - - 0.21
I Quarter March 0.00 - - -
FY   - 0.01 0.01 0.33

Financial Statements
Prolung Inc's first quarter 2017 Revenue $ 0.00 millions FRES's Income Statement
Prolung Inc's first quarter 2016 Revenue $ 0.00 millions Quarterly FRES's Income Statement
FRES's Growth by Division See FRES's Growth by Segment

FRES Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - - - -
III Quarter September - - -91.67 % -
II Quarter June - - - -
I Quarter March - - - -
FY   - 0 % -96.97 % -



FRES Revenue Growth Comment
Prolung Inc in the first quarter recorded of $ 0.00 millions.

According to the results reported in the first quarter, Prolung Inc achieved the best Revenue growth in Medical Laboratories industry. While Prolung Inc' s Revenue no change of % ranks overall at the positon no. in the first quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
S&P 500 #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

You need to upgrade your Flash Player

Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
FRES's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for FRES's Competitors
Revenue Growth for Prolung Inc's Suppliers
Revenue Growth for FRES's Customers

You may also want to know
FRES's Annual Growth Rates FRES's Profitability Ratios FRES's Asset Turnover Ratio FRES's Dividend Growth
FRES's Roe FRES's Valuation Ratios FRES's Financial Strength Ratios FRES's Dividend Payout Ratio
FRES's Roa FRES's Inventory Turnover Ratio FRES's Growth Rates FRES's Dividend Comparisons



Companies with similar Revenue no change for the quarter ending Mar 31 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2017
Utah Medical Products Inc -0.41 %$ -0.408 millions
Livanova Plc -0.65 %$ -0.650 millions
Tearlab Corp -0.98 %$ -0.975 millions
Parexel International Corp -1.01 %$ -1.014 millions
Alliqua Biomedical, Inc. -1.06 %$ -1.055 millions
Spark Therapeutics, Inc. -1.10 %$ -1.099 millions
Amgen Inc. -1.14 %$ -1.140 millions
Zynex Inc -1.18 %$ -1.179 millions
Biolase, Inc -1.24 %$ -1.235 millions
Ligand Pharmaceuticals Inc -1.29 %$ -1.285 millions
Seattle Genetics Inc -1.82 %$ -1.821 millions
Reliv International Inc -1.98 %$ -1.984 millions
Adaptimmune Therapeutics Plc -2.09 %$ -2.090 millions
Wright Medical Group N.v. -2.12 %$ -2.119 millions
Oncomed Pharmaceuticals Inc -2.16 %$ -2.157 millions
Prothena Corp Plc -2.26 %$ -2.264 millions
Antares Pharma, Inc. -2.53 %$ -2.527 millions
Integrated Biopharma Inc -2.89 %$ -2.889 millions
Allied Healthcare Products Inc -2.93 %$ -2.930 millions
Becton Dickinson & Co -3.20 %$ -3.195 millions
Encision Inc -3.36 %$ -3.361 millions
Infusystem Holdings, Inc -3.50 %$ -3.498 millions
Brookdale Senior Living Inc. -3.67 %$ -3.673 millions
Kindred Healthcare, Inc -3.79 %$ -3.785 millions
Tenet Healthcare Corp -4.13 %$ -4.133 millions
Chembio Diagnostics, Inc. -4.18 %$ -4.180 millions
Progenics Pharmaceuticals Inc -4.20 %$ -4.204 millions
Cas Medical Systems Inc -4.23 %$ -4.228 millions
Amphastar Pharmaceuticals, Inc. -4.54 %$ -4.541 millions
Strata Skin Sciences, Inc. -4.57 %$ -4.567 millions


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com